Treatment of preterm labor with 17 alpha-hydroxyprogesterone caproate [hydroxyprogesterone].
Withdrawn prior to enrolment
Phase of Trial: Phase III
Latest Information Update: 18 Sep 2012
At a glance
- Drugs Hydroxyprogesterone (Primary)
- Indications Pregnancy; Preterm birth
- Focus Therapeutic Use
- 18 Sep 2012 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov record.
- 27 Oct 2006 New trial record.